Global Molecular Targeted Therapy Market Research Report 2025(Status and Outlook)

March 2025 | 236 pages | ID: G5AC52097A97EN
Bosson Research

Abstracts

Report Overview

Molecular-targeted therapy is a novel strategy born from our increasing understanding of the underlying pathways and key molecules involved in tumor growth and progression. Theoretically, the specificity of molecular targeted therapy should improve the therapeutic window by affecting the tumor cells and sparing normal cell.

This report provides a deep insight into the global Molecular Targeted Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Molecular Targeted Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Molecular Targeted Therapy market in any manner.

Global Molecular Targeted Therapy Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Phoenix Molecular Designs

Prelude Therapeutics

Tempus

Bracco

iOmx Therapeutics

OncoDNA

Sapience Therapeutics

Caris Life Sciences

Hera Biolabs

CV6 Therapeutics

Carrick Therapeutics

Foundation Medicine

Cybrexa Therapeutics

Market Segmentation (by Type)

Monoclonal Antibodies

Small Molecule Inhibitors

Market Segmentation (by Application)

Lung Cancer

Breast Cancer

Colorectal Cancer

Leukemia

Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Molecular Targeted Therapy Market
• Overview of the regional outlook of the Molecular Targeted Therapy Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Molecular Targeted Therapy Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Molecular Targeted Therapy
1.2 Key Market Segments
  1.2.1 Molecular Targeted Therapy Segment by Type
  1.2.2 Molecular Targeted Therapy Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 GLOBAL MOLECULAR TARGETED THERAPY MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Molecular Targeted Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
  2.1.2 Global Molecular Targeted Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 GLOBAL MOLECULAR TARGETED THERAPY MARKET COMPETITIVE LANDSCAPE

3.1 Company Assessment Quadrant
3.2 Global Molecular Targeted Therapy Product Life Cycle
3.3 Global Molecular Targeted Therapy Sales by Manufacturers (2020-2025)
3.4 Global Molecular Targeted Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Molecular Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Molecular Targeted Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Molecular Targeted Therapy Manufacturing Sites, Area Served, Product Type
3.8 Molecular Targeted Therapy Market Competitive Situation and Trends
  3.8.1 Molecular Targeted Therapy Market Concentration Rate
  3.8.2 Global 5 and 10 Largest Molecular Targeted Therapy Players Market Share by Revenue
  3.8.3 Mergers & Acquisitions, Expansion

4 MOLECULAR TARGETED THERAPY INDUSTRY CHAIN ANALYSIS

4.1 Molecular Targeted Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF MOLECULAR TARGETED THERAPY MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
  5.4.1 New Product Developments
  5.4.2 Mergers & Acquisitions
  5.4.3 Expansions
  5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
  5.5.1 Industry Policies Analysis
  5.5.2 Economic Environment Analysis
  5.5.3 Social Environment Analysis
  5.5.4 Technological Environment Analysis
5.6 Global Molecular Targeted Therapy Market Porter's Five Forces Analysis
  5.6.1 Global Trade Frictions
  5.6.2 Global Trade Frictions and Their Impacts to Molecular Targeted Therapy Market
5.7 ESG Ratings of Leading Companies

6 GLOBAL MOLECULAR TARGETED THERAPY MARKET BY REGION

6.1 Global Molecular Targeted Therapy Market Size by Region
  6.1.1 Global Molecular Targeted Therapy Market Size by Region
  6.1.2 Global Molecular Targeted Therapy Market Size Market Share by Region
6.2 Global Molecular Targeted Therapy Sales by Region
  6.2.1 Global Molecular Targeted Therapy Sales by Region
  6.2.2 Global Molecular Targeted Therapy Sales Market Share by Region

7 NORTH AMERICA MARKET OVERVIEW

7.1 North America Molecular Targeted Therapy Market Size by Country
  7.1.1 USA Market Overview
  7.1.2 Canada Market Overview
  7.1.3 Mexico Market Overview
7.2 North America Molecular Targeted Therapy Market Size by Type
7.3 North America Molecular Targeted Therapy Market Size by Application

8 EUROPE MARKET OVERVIEW

8.1 Europe Molecular Targeted Therapy Market Size by Country
  8.1.1 Germany Market Overview
  8.1.2 France Market Overview
  8.1.3 U.K. Market Overview
  8.1.4 Italy Market Overview
  8.1.5 Spain Market Overview
8.2 Europe Molecular Targeted Therapy Market Size by Type
8.3 Europe Molecular Targeted Therapy Market Size by Application

9 ASIA-PACIFIC MARKET OVERVIEW

9.1 Asia-Pacific Molecular Targeted Therapy Market Size by Country
  9.1.1 China Market Overview
  9.1.2 Japan Market Overview
  9.1.3 South Korea Market Overview
  9.1.4 India Market Overview
  9.1.5 Southeast Asia Market Overview
9.2 Asia-Pacific Molecular Targeted Therapy Market Size by Type
9.3 Asia-Pacific Molecular Targeted Therapy Market Size by Application

10 SOUTH AMERICA MARKET OVERVIEW

10.1 South America Molecular Targeted Therapy Market Size by Country
  10.1.1 Brazil Market Overview
  10.1.2 Argentina Market Overview
  10.1.3 Columbia Market Overview
10.2 South America Molecular Targeted Therapy Market Size by Type
10.3 South America Molecular Targeted Therapy Market Size by Application

11 MIDDLE EAST AND AFRICA MARKET OVERVIEW

11.1 Middle East and Africa Molecular Targeted Therapy Market Size by Country
  11.1.1 Saudi Arabia Market Overview
  11.1.2 UAE Market Overview
  11.1.3 Egypt Market Overview
  11.1.4 Nigeria Market Overview
  11.1.5 South Africa Market Overview
11.2 Middle East and Africa Molecular Targeted Therapy Market Size by Type
11.3 Middle East and Africa Molecular Targeted Therapy Market Size by Application

12 MOLECULAR TARGETED THERAPY MARKET PRODUCTION BY REGION

12.1 Global Production of Molecular Targeted Therapy by Region(2020-2025)
12.2 Global Molecular Targeted Therapy Revenue Market Share by Region (2020-2025)
12.3 Global Molecular Targeted Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.4 North America Molecular Targeted Therapy Production
  12.4.1 North America Molecular Targeted Therapy Production Growth Rate (2020-2025)
  12.4.2 North America Molecular Targeted Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.5 Europe Molecular Targeted Therapy Production
  12.5.1 Europe Molecular Targeted Therapy Production Growth Rate (2020-2025)
  12.5.2 Europe Molecular Targeted Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.6 Japan Molecular Targeted Therapy Production (2020-2025)
  12.6.1 Japan Molecular Targeted Therapy Production Growth Rate (2020-2025)
  12.6.2 Japan Molecular Targeted Therapy Production, Revenue, Price and Gross Margin (2020-2025)
12.7 China Molecular Targeted Therapy Production (2020-2025)
  12.7.1 China Molecular Targeted Therapy Production Growth Rate (2020-2025)
  12.7.2 China Molecular Targeted Therapy Production, Revenue, Price and Gross Margin (2020-2025)

13 MOLECULAR TARGETED THERAPY MARKET SEGMENTATION BY TYPE

13.1 Evaluation Matrix of Segment Market Development Potential (Type)
13.2 Global Molecular Targeted Therapy Sales Market Share by Type (2020-2033)
13.3 Global Molecular Targeted Therapy Market Size Market Share by Type (2020-2033)
13.4 Global Molecular Targeted Therapy Price by Type (2020-2033)

14 MOLECULAR TARGETED THERAPY MARKET SEGMENTATION BY APPLICATION

14.1 Evaluation Matrix of Segment Market Development Potential (Application)
14.2 Global Molecular Targeted Therapy Market Sales by Application (2020-2033)
14.3 Global Molecular Targeted Therapy Market Size (M USD) by Application (2020-2033)
14.4 Global Molecular Targeted Therapy Sales Growth Rate by Application (2020-2033)

15 KEY COMPANIES PROFILE

15.1 Phoenix Molecular Designs
  15.1.1 Phoenix Molecular Designs Basic Information
  15.1.2 Phoenix Molecular Designs Molecular Targeted Therapy Product Overview
  15.1.3 Phoenix Molecular Designs Molecular Targeted Therapy Product Market Performance
  15.1.4 Phoenix Molecular Designs Business Overview
  15.1.5 Phoenix Molecular Designs SWOT Analysis
  15.1.6 Phoenix Molecular Designs Recent Developments
15.2 Prelude Therapeutics
  15.2.1 Prelude Therapeutics Basic Information
  15.2.2 Prelude Therapeutics Molecular Targeted Therapy Product Overview
  15.2.3 Prelude Therapeutics Molecular Targeted Therapy Product Market Performance
  15.2.4 Prelude Therapeutics Business Overview
  15.2.5 Prelude Therapeutics SWOT Analysis
  15.2.6 Prelude Therapeutics Recent Developments
15.3 Tempus
  15.3.1 Tempus Basic Information
  15.3.2 Tempus Molecular Targeted Therapy Product Overview
  15.3.3 Tempus Molecular Targeted Therapy Product Market Performance
  15.3.4 Tempus Business Overview
  15.3.5 Tempus SWOT Analysis
  15.3.6 Tempus Recent Developments
15.4 Bracco
  15.4.1 Bracco Basic Information
  15.4.2 Bracco Molecular Targeted Therapy Product Overview
  15.4.3 Bracco Molecular Targeted Therapy Product Market Performance
  15.4.4 Bracco Business Overview
  15.4.5 Bracco Recent Developments
15.5 iOmx Therapeutics
  15.5.1 iOmx Therapeutics Basic Information
  15.5.2 iOmx Therapeutics Molecular Targeted Therapy Product Overview
  15.5.3 iOmx Therapeutics Molecular Targeted Therapy Product Market Performance
  15.5.4 iOmx Therapeutics Business Overview
  15.5.5 iOmx Therapeutics Recent Developments
15.6 OncoDNA
  15.6.1 OncoDNA Basic Information
  15.6.2 OncoDNA Molecular Targeted Therapy Product Overview
  15.6.3 OncoDNA Molecular Targeted Therapy Product Market Performance
  15.6.4 OncoDNA Business Overview
  15.6.5 OncoDNA Recent Developments
15.7 Sapience Therapeutics
  15.7.1 Sapience Therapeutics Basic Information
  15.7.2 Sapience Therapeutics Molecular Targeted Therapy Product Overview
  15.7.3 Sapience Therapeutics Molecular Targeted Therapy Product Market Performance
  15.7.4 Sapience Therapeutics Business Overview
  15.7.5 Sapience Therapeutics Recent Developments
15.8 Caris Life Sciences
  15.8.1 Caris Life Sciences Basic Information
  15.8.2 Caris Life Sciences Molecular Targeted Therapy Product Overview
  15.8.3 Caris Life Sciences Molecular Targeted Therapy Product Market Performance
  15.8.4 Caris Life Sciences Business Overview
  15.8.5 Caris Life Sciences Recent Developments
15.9 Hera Biolabs
  15.9.1 Hera Biolabs Basic Information
  15.9.2 Hera Biolabs Molecular Targeted Therapy Product Overview
  15.9.3 Hera Biolabs Molecular Targeted Therapy Product Market Performance
  15.9.4 Hera Biolabs Business Overview
  15.9.5 Hera Biolabs Recent Developments
15.10 CV6 Therapeutics
  15.10.1 CV6 Therapeutics Basic Information
  15.10.2 CV6 Therapeutics Molecular Targeted Therapy Product Overview
  15.10.3 CV6 Therapeutics Molecular Targeted Therapy Product Market Performance
  15.10.4 CV6 Therapeutics Business Overview
  15.10.5 CV6 Therapeutics Recent Developments
15.11 Carrick Therapeutics
  15.11.1 Carrick Therapeutics Basic Information
  15.11.2 Carrick Therapeutics Molecular Targeted Therapy Product Overview
  15.11.3 Carrick Therapeutics Molecular Targeted Therapy Product Market Performance
  15.11.4 Carrick Therapeutics Business Overview
  15.11.5 Carrick Therapeutics Recent Developments
15.12 Foundation Medicine
  15.12.1 Foundation Medicine Basic Information
  15.12.2 Foundation Medicine Molecular Targeted Therapy Product Overview
  15.12.3 Foundation Medicine Molecular Targeted Therapy Product Market Performance
  15.12.4 Foundation Medicine Business Overview
  15.12.5 Foundation Medicine Recent Developments
15.13 Cybrexa Therapeutics
  15.13.1 Cybrexa Therapeutics Basic Information
  15.13.2 Cybrexa Therapeutics Molecular Targeted Therapy Product Overview
  15.13.3 Cybrexa Therapeutics Molecular Targeted Therapy Product Market Performance
  15.13.4 Cybrexa Therapeutics Business Overview
  15.13.5 Cybrexa Therapeutics Recent Developments

16 CONCLUSION AND KEY FINDINGS
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Molecular Targeted Therapy Market Size by Type (M USD)
Table 4. Global Molecular Targeted Therapy Market Size by Application (M USD)
Table 5. Molecular Targeted Therapy Market Size Comparison by Region (M USD)
Table 6. Global Molecular Targeted Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Molecular Targeted Therapy Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Molecular Targeted Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Molecular Targeted Therapy Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Targeted Therapy as of 2024)
Table 11. Global Market Molecular Targeted Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers Molecular Targeted Therapy Manufacturing Sites and Area Served
Table 13. Manufacturers Molecular Targeted Therapy Product Type
Table 14. Global Molecular Targeted Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Molecular Targeted Therapy Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 25. Molecular Targeted Therapy Market Size Comparison by Region (M USD)
Table 26. Global Molecular Targeted Therapy Market Size by Region (2020-2033) & (M USD)
Table 27. Global Molecular Targeted Therapy Market Size Market Share by Region (2020-2033)
Table 28. Global Molecular Targeted Therapy Sales by Region (2020-2033) & (K Units)
Table 29. Global Molecular Targeted Therapy Sales Market Share by Region (2020-2033)
Table 30. North America Molecular Targeted Therapy Market Size by Country (2020-2033) & (M USD)
Table 31. North America Molecular Targeted Therapy Sales by Country (2020-2033) & (K Units)
Table 32. North America Molecular Targeted Therapy Sales by Type (K Units)
Table 33. North America Molecular Targeted Therapy Market Size by Type (M USD)
Table 34. North America Molecular Targeted Therapy Sales (K Units) by Type (2020-2033)
Table 35. North America Molecular Targeted Therapy Market Size (M USD) by Type (2020-2033)
Table 36. North America Molecular Targeted Therapy Sales by Application (K Units)
Table 37. North America Molecular Targeted Therapy Market Size by Application (M USD)
Table 38. North America Molecular Targeted Therapy Sales (K Units) by Application (2020-2033)
Table 39. North America Molecular Targeted Therapy Market Size (M USD) by Application (2020-2033)
Table 40. Europe Molecular Targeted Therapy Market Size by Country (2020-2033) & (M USD)
Table 41. Europe Molecular Targeted Therapy Sales by Country (2020-2033) & (K Units)
Table 42. Europe Molecular Targeted Therapy Sales by Type (K Units)
Table 43. Europe Molecular Targeted Therapy Market Size by Type (M USD)
Table 44. Europe Molecular Targeted Therapy Sales (K Units) by Type (2020-2033)
Table 45. Europe Molecular Targeted Therapy Market Size (M USD) by Type (2020-2033)
Table 46. Europe Molecular Targeted Therapy Sales by Application (K Units)
Table 47. Europe Molecular Targeted Therapy Market Size by Application (M USD)
Table 48. Europe Molecular Targeted Therapy Sales (K Units) by Application (2020-2033)
Table 49. Europe Molecular Targeted Therapy Market Size (M USD) by Application (2020-2033)
Table 50. Asia-Pacific Molecular Targeted Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Asia-Pacific Molecular Targeted Therapy Sales by Country (2020-2025) & (K Units)
Table 52. Asia-Pacific Molecular Targeted Therapy Sales by Type (K Units)
Table 53. Asia-Pacific Molecular Targeted Therapy Market Size by Type (M USD)
Table 54. Asia-Pacific Molecular Targeted Therapy Sales (K Units) by Type (2020-2033)
Table 55. Asia-Pacific Molecular Targeted Therapy Market Size (M USD) by Type (2020-2025)
Table 56. Asia-Pacific Molecular Targeted Therapy Sales by Application (K Units)
Table 57. Asia-Pacific Molecular Targeted Therapy Market Size by Application (M USD)
Table 58. Asia-Pacific Molecular Targeted Therapy Sales (K Units) by Application (2020-2033)
Table 59. Asia-Pacific Molecular Targeted Therapy Market Size (M USD) by Application (2020-2025)
Table 60. South America Molecular Targeted Therapy Market Size by Country (2020-2033) & (M USD)
Table 61. South America Molecular Targeted Therapy Sales by Country (2020-2033) & (K Units)
Table 62. South America Molecular Targeted Therapy Sales by Type (K Units)
Table 63. South America Molecular Targeted Therapy Market Size by Type (M USD)
Table 64. South America Molecular Targeted Therapy Sales (K Units) by Type (2020-2033)
Table 65. South America Molecular Targeted Therapy Market Size (M USD) by Type (2020-2033)
Table 66. South America Molecular Targeted Therapy Sales by Application (K Units)
Table 67. South America Molecular Targeted Therapy Market Size by Application (M USD)
Table 68. South America Molecular Targeted Therapy Sales (K Units) by Application (2020-2033)
Table 69. South America Molecular Targeted Therapy Market Size (M USD) by Application (2020-2033)
Table 70. Middle East and Africa Molecular Targeted Therapy Market Size by Country (2020-2033) & (M USD)
Table 71. Middle East and Africa Molecular Targeted Therapy Sales by Country (2020-2033) & (K Units)
Table 72. Middle East and Africa Molecular Targeted Therapy Sales by Type (K Units)
Table 73. Middle East and Africa Molecular Targeted Therapy Market Size by Type (M USD)
Table 74. Middle East and Africa Molecular Targeted Therapy Sales (K Units) by Type (2020-2033)
Table 75. Middle East and Africa Molecular Targeted Therapy Market Size (M USD) by Type (2020-2033)
Table 76. Middle East and Africa Molecular Targeted Therapy Sales by Application (K Units)
Table 77. Middle East and Africa Molecular Targeted Therapy Market Size by Application (M USD)
Table 78. Middle East and Africa Molecular Targeted Therapy Sales (K Units) by Application (2020-2033)
Table 79. Middle East and Africa Molecular Targeted Therapy Market Size (M USD) by Application (2020-2033)
Table 80. Global Molecular Targeted Therapy Production (K Units) by Region(2020-2025)
Table 81. Global Molecular Targeted Therapy Revenue (US$ Million) by Region (2020-2025)
Table 82. Global Molecular Targeted Therapy Revenue Market Share by Region (2020-2025)
Table 83. Global Molecular Targeted Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 84. North America Molecular Targeted Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Europe Molecular Targeted Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Japan Molecular Targeted Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. China Molecular Targeted Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Global Molecular Targeted Therapy Sales by Type (K Units)
Table 89. Global Molecular Targeted Therapy Market Size by Type (M USD)
Table 90. Global Molecular Targeted Therapy Sales (K Units) by Type (2020-2033)
Table 91. Global Molecular Targeted Therapy Sales Market Share by Type (2020-2033)
Table 92. Global Molecular Targeted Therapy Market Size (M USD) by Type (2020-2033)
Table 93. Global Molecular Targeted Therapy Market Size Share by Type (2020-2033)
Table 94. Global Molecular Targeted Therapy Sales (K Units) by Application
Table 95. Global Molecular Targeted Therapy Market Size by Application(M USD)
Table 96. Global Molecular Targeted Therapy Sales by Application (2020-2033) & (K Units)
Table 97. Global Molecular Targeted Therapy Sales Market Share by Application (2020-2033)
Table 98. Global Molecular Targeted Therapy Market Size by Application (2020-2033) & (M USD)
Table 99. Global Molecular Targeted Therapy Market Share by Application (2020-2033)
Table 100. Global Molecular Targeted Therapy Sales Growth Rate by Application (2020-2033)
Table 101. Phoenix Molecular Designs Basic Information
Table 102. Phoenix Molecular Designs Molecular Targeted Therapy Product Overview
Table 103. Phoenix Molecular Designs Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 104. Phoenix Molecular Designs Business Overview
Table 105. Phoenix Molecular Designs SWOT Analysis
Table 106. Phoenix Molecular Designs Recent Developments
Table 107. Prelude Therapeutics Basic Information
Table 108. Prelude Therapeutics Molecular Targeted Therapy Product Overview
Table 109. Prelude Therapeutics Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 110. Prelude Therapeutics Business Overview
Table 111. Prelude Therapeutics SWOT Analysis
Table 112. Prelude Therapeutics Recent Developments
Table 113. Tempus Basic Information
Table 114. Tempus Molecular Targeted Therapy Product Overview
Table 115. Tempus Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Tempus Business Overview
Table 117. Tempus SWOT Analysis
Table 118. Tempus Recent Developments
Table 119. Bracco Basic Information
Table 120. Bracco Molecular Targeted Therapy Product Overview
Table 121. Bracco Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Bracco Business Overview
Table 123. Bracco Recent Developments
Table 124. iOmx Therapeutics Basic Information
Table 125. iOmx Therapeutics Molecular Targeted Therapy Product Overview
Table 126. iOmx Therapeutics Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. iOmx Therapeutics Business Overview
Table 128. iOmx Therapeutics Recent Developments
Table 129. OncoDNA Basic Information
Table 130. OncoDNA Molecular Targeted Therapy Product Overview
Table 131. OncoDNA Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. OncoDNA Business Overview
Table 133. OncoDNA Recent Developments
Table 134. Sapience Therapeutics Basic Information
Table 135. Sapience Therapeutics Molecular Targeted Therapy Product Overview
Table 136. Sapience Therapeutics Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Sapience Therapeutics Business Overview
Table 138. Sapience Therapeutics Recent Developments
Table 139. Caris Life Sciences Basic Information
Table 140. Caris Life Sciences Molecular Targeted Therapy Product Overview
Table 141. Caris Life Sciences Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Caris Life Sciences Business Overview
Table 143. Caris Life Sciences Recent Developments
Table 144. Hera Biolabs Basic Information
Table 145. Hera Biolabs Molecular Targeted Therapy Product Overview
Table 146. Hera Biolabs Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 147. Hera Biolabs Business Overview
Table 148. Hera Biolabs Recent Developments
Table 149. CV6 Therapeutics Basic Information
Table 150. CV6 Therapeutics Molecular Targeted Therapy Product Overview
Table 151. CV6 Therapeutics Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 152. CV6 Therapeutics Business Overview
Table 153. CV6 Therapeutics Recent Developments
Table 154. Carrick Therapeutics Basic Information
Table 155. Carrick Therapeutics Molecular Targeted Therapy Product Overview
Table 156. Carrick Therapeutics Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 157. Carrick Therapeutics Business Overview
Table 158. Carrick Therapeutics Recent Developments
Table 159. Foundation Medicine Basic Information
Table 160. Foundation Medicine Molecular Targeted Therapy Product Overview
Table 161. Foundation Medicine Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 162. Foundation Medicine Business Overview
Table 163. Foundation Medicine Recent Developments
Table 164. Cybrexa Therapeutics Basic Information
Table 165. Cybrexa Therapeutics Molecular Targeted Therapy Product Overview
Table 166. Cybrexa Therapeutics Molecular Targeted Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 167. Cybrexa Therapeutics Business Overview
Table 168. Cybrexa Therapeutics Recent Developments
List of Figures
Figure 1. Product Picture of Molecular Targeted Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Molecular Targeted Therapy Market Size (M USD), 2024-2033
Figure 5. Global Molecular Targeted Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Molecular Targeted Therapy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Molecular Targeted Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Molecular Targeted Therapy Product Life Cycle
Figure 13. Molecular Targeted Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Molecular Targeted Therapy Revenue Share by Manufacturers in 2024
Figure 15. Molecular Targeted Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Molecular Targeted Therapy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Molecular Targeted Therapy Revenue in 2024
Figure 18. Industry Chain Map of Molecular Targeted Therapy
Figure 19. Global Molecular Targeted Therapy Market PEST Analysis
Figure 20. Global Molecular Targeted Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Regional Market Development Potential
Figure 26. Global Molecular Targeted Therapy Market Size by Region
Figure 27. Global Molecular Targeted Therapy Market Size Market Share by Region (2020-2033)
Figure 28. Global Molecular Targeted Therapy Sales Market Share by Region (2020-2033)
Figure 29. North American Market Snapshot
Figure 30. North America Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 31. North America Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 32. North America Molecular Targeted Therapy Market Size (M USD) by Country
Figure 33. USA Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 34. USA Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 35. Canada Molecular Targeted Therapy Sales (K Units) and Growth Rate (2020-2033)
Figure 36. Canada Molecular Targeted Therapy Market Size (M USD) and Growth Rate (2020-2033)
Figure 37. Mexico Molecular Targeted Therapy Sales (Units) and Growth Rate (2020-2033)
Figure 38. Mexico Molecular Targeted Therapy Market Size (M USD) and Growth Rate (2020-2033)
Figure 39. North America Molecular Targeted Therapy Market Size (M USD)by Type
Figure 40. North America Molecular Targeted Therapy Market Size (M USD) by Application
Figure 41. Europe Market Snapshot
Figure 42. Europe Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 43. Europe Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 44. Europe Molecular Targeted Therapy Market Size (M USD) by Country
Figure 45. Germany Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 46. Germany Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 47. France Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 48. France Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 49. U.K. Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 50. U.K. Molecular Targeted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 51. Italy Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 52. Italy Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 53. Spain Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 54. Spain Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 55. Europe Molecular Targeted Therapy Market Size (M USD) by Type
Figure 56. Europe Molecular Targeted Therapy Market Size (M USD) by Application
Figure 57. Asia-Pacific Market Snapshot
Figure 58. Asia-Pacific Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 59. Asia-Pacific Molecular Targeted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Asia-Pacific Molecular Targeted Therapy Market Size (M USD) by Country
Figure 61. China Molecular Targeted Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. China Molecular Targeted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Japan Molecular Targeted Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Japan Molecular Targeted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. South Korea Molecular Targeted Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 66. South Korea Molecular Targeted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 67. India Molecular Targeted Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 68. India Molecular Targeted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Southeast Asia Molecular Targeted Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 70. Southeast Asia Molecular Targeted Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. Asia-Pacific Molecular Targeted Therapy Market Size (M USD) by Type
Figure 72. Asia-Pacific Molecular Targeted Therapy Market Size (M USD) by Application
Figure 73. South America Market Snapshot
Figure 74. South America Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 75. South America Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 76. South America Molecular Targeted Therapy Market Size (M USD) by Country
Figure 77. Brazil Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 78. Brazil Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 79. Argentina Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 80. Argentina Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 81. Columbia Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 82. Columbia Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 83. South America Molecular Targeted Therapy Market Size (M USD) by Type
Figure 84. South America Molecular Targeted Therapy Market Size (M USD) by Application
Figure 85. Middle East and Africa Market Snapshot
Figure 86. Middle East and Africa Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 87. Middle East and Africa Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 88. Middle East and Africa Molecular Targeted Therapy Market Size (M USD) by Country
Figure 89. Saudi Arabia Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 90. Saudi Arabia Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 91. UAE Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 92. UAE Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 93. Egypt Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 94. Egypt Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 95. Nigeria Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 96. Nigeria Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 97. South Africa Molecular Targeted Therapy Sales and Growth Rate (2020-2033) & (K Units)
Figure 98. South Africa Molecular Targeted Therapy Market Size and Growth Rate (2020-2033) & (M USD)
Figure 99. Middle East and Africa Molecular Targeted Therapy Market Size (M USD) by Type
Figure 100. Middle East and Africa Molecular Targeted Therapy Market Size (M USD) by Application
Figure 101. Global Molecular Targeted Therapy Production Market Share by Region (2020-2025)
Figure 102. North America Molecular Targeted Therapy Production (K Units) Growth Rate (2020-2025)
Figure 103. Europe Molecular Targeted Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Japan Molecular Targeted Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. China Molecular Targeted Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 107. Global Molecular Targeted Therapy Market Size by Type (M USD)
Figure 108. Sales Market Share of Molecular Targeted Therapy by Type (2020-2033)
Figure 109. Sales Market Share of Molecular Targeted Therapy by Type in 2024
Figure 110. Market Size Share of Molecular Targeted Therapy by Type (2020-2033)
Figure 111. Market Size Share of Molecular Targeted Therapy by Type in 2024
Figure 112. Global Molecular Targeted Therapy Price (USD/Unit) by Type (2020-2033)
Figure 113. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 114. Global Molecular Targeted Therapy Market Size by Application(M USD)
Figure 115. Global Molecular Targeted Therapy Market Share by Application
Figure 116. Global Molecular Targeted Therapy Sales Market Share by Application (2020-2033)
Figure 117. Global Molecular Targeted Therapy Sales Market Share by Application in 2024
Figure 118. Global Molecular Targeted Therapy Market Share by Application (2020-2033)
Figure 119. Global Molecular Targeted Therapy Market Share by Application in 2024
Figure 120. Global Molecular Targeted Therapy Sales Growth Rate by Application (2020-2033)